Chitty et al. have demonstrated that pan-lysyl oxidase inhibition significantly reduces chemotherapy-induced pancreatic tumor desmoplasia and stiffness, both in vitro and in vivo [50]. Here, LOX is linked to pancreatic neoplasm.